Episode 53: Frank David, Founder and Managing Director, Pharmagellan

from Few & Far Between: How Biotech Gets Built · host Chris O'Brien

How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan to the podcast. Tune in as we explore R&D strategy, de-risking tactics, and how to think about valuation. Listen in to the latest episode of the Biorasi Few & Far Between podcast today!

Episode metadata supplied by the publisher feed · Published Apr 29, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

0:00 50:46

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

The SharePoint Helpdesk Founder: Stop Inputting Data Into Spreadsheets | E39

Jun 25, 2024 ·53m

Episode 30 - How to Read and Interpret a Balance Sheet – Part 5

Jan 27, 2024 ·12m

Episode 28 - How to Read and Interpret a Balance Sheet – Part 4

Jan 19, 2024 ·9m

Episode 27 - How to Read and Interpret a Balance Sheet – Part 3

Jan 18, 2024 ·5m

Episode 26 - How to Read and Interpret a Balance Sheet – Part 2

Jan 14, 2024 ·6m

Episode 25 - How To Read And Interpret A Balance Sheet - Part 1

Jan 5, 2024 ·7m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Few & Far Between: How Biotech Gets Built?

This episode is 50 minutes long.

When was this Few & Far Between: How Biotech Gets Built episode published?

This episode was published on April 29, 2025.

Can I download this Few & Far Between: How Biotech Gets Built episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!